Treatment of Hemorrhoids with Individualized Homeopathic Medicinal Products: A Double-Blind, Randomized, Placebo-Controlled Trial
Journal of Integrative and Complementary Medicine · 2026
DOI: 10.1177/27683605261435779 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Integrative and Complementary Medicine, 2026. Verfasst von Ankit Saha und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Repertory, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India. Hauptthemen laut MEDLINE: Hemorrhoids, Homeopathy, Materia Medica. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Context
Anecdotal reports and preliminary clinical observations suggest potential benefits of homeopathic medicines in hemorrhoids, but high-quality evidence remains limited.
Objective
To evaluate whether individualized homeopathic medicinal products (IHMPs) are superior to placebo in reducing anorectal symptom severity and improving quality of life over 3 months in adults with hemorrhoids, and to assess their safety and tolerability.
Design
Three-month, double-blind, randomized (1:1), placebo-controlled trial.
Setting
Surgery, PG3, and research outpatients of a tertiary homeopathic medical college hospital in West Bengal, India. Patients: One hundred and thirty-four adults with grade I–III hemorrhoids.
Intervention
IHMPs (verum; n = 67) or identical-looking placebos (control; n = 67) both administered alongside standard concomitant care including sitz baths, pelvic floor exercises, and dietary advice. Main Outcome Measures: The primary outcome was the change in the Anorectal Symptom Severity and Quality-of-Life (ARSSQoL) total score over 3 months. Secondary outcomes included ARSSQoL subscales, numeric rating scales (NRSs), and EQ-5D-5L questionnaire and visual analog scale. Outcomes were assessed monthly for up to 3 months. The primary analysis compared model-based estimates of change over time between groups using repeated measures analysis of variance; the secondary analyses comprised multivariate linear mixed models, Bayesian hierarchical modeling, and sensitivity analyses under intention-to-treat and per-protocol frameworks.
Results
After 3 months, IHMPs demonstrated significantly greater improvement than placebo in ARSSQoL total (mean group difference −6.5, 95% confidence interval −8.7, −4.2; p < 0.001), with large effect sizes. Most ARSSQoL subscales, NRSs, and EQ-5D-5L scores favored IHMPs. Multivariate and Bayesian analyses confirmed consistent intervention-by-time effects, with a high probability of directional superiority for IHMPs in symptom reduction and self-rated health, while sensitivity analyses showed the findings to be robust to protocol deviations. Kent’s repertory was the most frequently used in remedy selection. Nitricum acidum emerged as the most effective remedy. No treatment-related serious adverse events were observed.
Conclusion
In this randomized, double-blind trial, IHMPs were associated with greater reductions in the ARSSQoL improvements in quality of life compared with placebo over 3 months. Although the magnitude and consistency of effects across multiple analytic approaches suggest potential clinical relevance, the absence of a validated minimal clinically important difference for the ARSSQoL warrants cautious interpretation. Further independent replications and methodological refinement of outcome thresholds are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Repertory, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
- East Bishnupur State Homoeopathic Dispensary, Chandi Daulatabad Block Primary Health Centre, under Department of Health & Family Welfare, Government of West Bengal, Parganas, India.
- Department of Pathology & Microbiology, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
- Department of Organon of Medicine and Homoeopathic Philosophy, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
- Department of Materia Medica, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
- Department of Organon of Medicine and Homoeopathic Philosophy, National Institute of Homoeopathy, Ministry of AYUSH, Government of India, Salt Lake, Kolkata, India.
ORCID-Profile: Subhranil Saha, Shubhamoy Ghosh
Zitieren
APA
Saha, A., Alam, S. M., Pal, R. K., Saha, S., Koley, M., Ghosh, S., Saha, S., Bhattacharyya, S., Muduli, S., Halder, I., Koley, M., Gunin, A., Das, S., Chakraborty, D., Shaikh, A. R., Ghosh, P., Sadhukhan, S., & Mukherjee, S. K. (2026). Treatment of Hemorrhoids with Individualized Homeopathic Medicinal Products: A Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Integrative and Complementary Medicine. https://doi.org/10.1177/27683605261435779
Vancouver
Saha A, Alam SM, Pal RK, Saha S, Koley M, Ghosh S, et al. Treatment of Hemorrhoids with Individualized Homeopathic Medicinal Products: A Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Integrative and Complementary Medicine. 2026. doi:10.1177/27683605261435779
BibTeX
@article{Saha2026,
author = {Saha, Ankit and Alam, Sk Monsur and Pal, Rajat Kumar and Saha, Subhranil and Koley, Munmun and Ghosh, Shubhamoy and Saha, Sangita and Bhattacharyya, Soumya and Muduli, Sagarika and Halder, Indrani and Koley, Mousumi and Gunin, Amit and Das, Suhisna and Chakraborty, Doly and Shaikh, Abdur Rahaman and Ghosh, Priyanka and Sadhukhan, Satarupa and Mukherjee, Shyamal Kumar},
title = {Treatment of Hemorrhoids with Individualized Homeopathic Medicinal Products: A Double-Blind, Randomized, Placebo-Controlled Trial},
journal = {Journal of Integrative and Complementary Medicine},
year = {2026},
doi = {10.1177/27683605261435779}
}
EUVIMED